Related Experiment Videos

TNF alpha-induced activation of eosinophil oxidative metabolism and morphology--comparison with IL-5

G Zeck-Kapp1, W Czech, A Kapp

  • 1Department of Dermatology, University of Freiburg, Germany.

Insights

Tumor Necrosis Factor alpha (TNF alpha) activates human eosinophils, inducing morphological changes and reactive oxygen species production. This cytokine plays a role in allergic inflammation by influencing eosinophil function.

Area of Science:

  • Immunology
  • Cell Biology
  • Inflammation Research

Background:

  • Human mast cells release cytokines, including Tumor Necrosis Factor alpha (TNF alpha), upon stimulation.
  • Mast cell activation involves inflammatory cell recruitment, including polymorphonuclear neutrophilic granulocytes (PMN) and eosinophils.
  • The precise mechanisms by which TNF alpha influences eosinophil activation remain incompletely understood.

Purpose of the Study:

  • To investigate the effects of TNF alpha on the morphology and function of highly purified human eosinophils.
  • To elucidate the signaling pathways and receptor interactions involved in TNF alpha-mediated eosinophil activation.
  • To assess the role of TNF alpha in the context of allergic inflammatory responses.

Main Methods:

  • Transmission and scanning electron microscopy to analyze eosinophil morphology.
  • Lucigenin-dependent chemiluminescence to measure reactive oxygen species (ROS) production.
  • Functional assays with inhibitors (cytochalasin B, staurosporin, pertussis toxin) and density gradient separation.
  • Flow cytometry (FACS) and immune electron microscopy to detect TNF receptors.
  • ELISA and functional assays to measure eosinophil cationic protein (ECP) and eosinophil peroxidase (EPO) release.

Main Results:

  • TNF alpha induced adherence, flattening, and a "hemispheric" shape in eosinophils.
  • A dose-dependent, long-lasting production of ROS was observed, though less potent than IL-5.
  • TNF alpha-induced responses were modulated by cytochalasin B, staurosporin, and pertussis toxin, suggesting complex signaling.
  • Two hypodense eosinophil populations exhibited differential susceptibility to TNF alpha.
  • ROS production was primarily extracellular, localized to cell contact zones.
  • TNF alpha binding to 55 kDa and 75 kDa TNF receptors was confirmed.
  • TNF alpha did not significantly induce the release of ECP or EPO.

Conclusions:

  • TNF alpha is a potent activator of human eosinophils, influencing their morphology and oxidative burst.
  • The activation involves specific TNF receptors and complex intracellular signaling pathways.
  • TNF alpha's role in allergic inflammation may be mediated through eosinophil activation without significant degranulation.

Related Concept Videos